Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered ...

The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 ...

CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics’ ...

The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...

Thomas Yau and colleagues’ CheckMate 9DW trial has yielded unprecedented results, with nivolumab plus ipilimumab reaching an overall response rate of 36%, a median progression-free survival of 9·1 ...

As an electrical engineer investigating early neural networks in the 1990s, I dreamed of a future where artificial ...

Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard ...

Scientists stated hearing loss requires to be added to the increasing list of complications associated with type 2 diabetes.Individuals with type 2 diabetes were at a significantly higher risk of ...

Our data at ASH 2025 raises the bar for patient and physician expectations of what’s possible. Our long-term data drives confidence in duration of response in CLL treatment decisions,” said Lai Wang, ...

We thank Akhil Santhosh and Nihanthy D Sreenath and Liting Zhang and colleagues for their interest in our trial. The CheckMate 9DW trial showed clinically significant overall survival benefit for ...